SURVIVAL OUTCOMES AFTER LEFT MAIN CORONARY ARTERY BYPASS GRAFTING VERSUS STENTING IN DIABETIC PATIENTS: INSIGHTS FROM PAKISTAN
Main Article Content
Keywords
Coronary artery disease, Diabetes, Coronary artery bypass grafting, Percutaneous coronary intervention, Long-term survival
Abstract
Background: Coronary artery disease (CAD) remains a leading cause of morbidity and mortality, particularly among diabetic patients. The optimal revascularization strategy for diabetic patients with left main coronary artery disease remains controversial. This study compares the long-term survival outcomes and quality of life between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) with stenting in diabetic patients.
Methods: This prospective cohort study was conducted at a tertiary care hospital in Pakistan from January 2018 to December 2023. A total of 303 diabetic patients with left main coronary artery disease were randomized to receive either CABG (n=152) or PCI with stenting (n=151). Data on demographics, clinical histories, and outcomes were collected at baseline, 1 month, 6 months, 1 year, and annually up to 5 years. Primary outcomes included all-cause mortality and major adverse cardiac events (MACE). Secondary outcomes included rehospitalization for cardiac causes and quality of life assessed by the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Statistical analysis was performed using SPSS version 25.0, with survival curves estimated using the Kaplan-Meier method and comparisons made using the log-rank test.
Results: At the 5-year follow-up, the CABG group exhibited significantly lower rates of all-cause mortality (10% vs. 20%, p<0.05) and MACE (25% vs. 35%, p<0.05) compared to the PCI group. Rehospitalization rates were lower (30% vs. 45%, p<0.01), and quality of life scores were higher (25 ± 5 vs. 35 ± 6, p<0.01) in the CABG group. Cox proportional hazards regression analysis indicated that CABG was associated with a significantly lower hazard ratio for all-cause mortality and MACE after adjusting for covariates.
Conclusion: CABG offers superior long-term survival and quality of life compared to PCI in diabetic patients with left main coronary artery disease. These findings support CABG as the preferred revascularization strategy in this high-risk population, underscoring the need for personalized treatment planning in complex cardiac interventions.
References
2. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised clinical SYNTAX trial. Lancet. 2013 Feb 23;381(9867):629-38.
3. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for Multivessel Revascularization in Patients with Diabetes. N Engl J Med. 2012 Dec 20;367(25):2375-84.
4. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009 Mar 5;360(10):961-72.
5. Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014 Oct 1;35(37):2541-619.
6. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994 Aug 27;344(8922):563-70.
7. Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J. 2005 Aug;150(2):221-6. doi: 10.1016/j.ahj.2004.09.025. PMID: 16086922.
8. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet. 2001 Oct 6;358(9285):870-5.
9. Benedetto U, Raja SG, Albanese A, et al. Minimally invasive coronary artery bypass grafting with single versus bilateral internal thoracic arteries: A propensity score analysis. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2988-95.e1.
10. Stone GW, Sabik JF, Serruys PW, et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016 Dec 8;375(23):2223-35.
11. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009 Apr 25;373(9670):1190-7.
12. Gersh BJ, Frye RL. Coronary Artery Bypass Surgery in Diabetic Patients: Implications of the Bypass Angioplasty Revascularization Investigation (BARI) Study. Circulation. 1999;99(6):847-51.
13. Sedlis SP, Hartigan PM, Teo KK, et al. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. N Engl J Med. 2015 Feb 19;372(18):1791-800.
14. Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease. N Engl J Med. 2015 Sep 10;373(11):1044-54.
15. Thuijs D, Kappetein AP, Serruys PW, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019 Mar 16;393(10175):1325-34.
16. Head SJ, Milojevic M, Daemen J, et al. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. J Am Coll Cardiol. 2018 Oct 16;72(16):1897-1906.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Fahad Raja Khan
Cardiologist, Lady Reading Hospital, Peshawar, Pakistan.Dr Muhammad Abdur Rauf
Assistant Professor of Cardiology, Kuwait Teaching Hospital/Peshawar Medical College Peshawar, Pakistan.
Dr Umera Ali
Clinical Fellow, NICVD, Karachi, Pakistan.Dr Asif Khan
Registrar Internal Medicine, Khyber Teaching Hospital, Peshawar, Pakistan.